Filter
289
Text search:
chemoprophylaxis
Featured
Recommendations
39
New Publications
73
Language
Document type
No document type
167
Guidelines
59
Studies & Reports
25
Manuals
16
Strategic & Response Plan
7
Training Material
5
Fact sheets
4
Infographics
3
Resource Platforms
2
Brochures
1
Countries / Regions
India
29
Global
15
South Africa
12
Western and Central Europe
10
Ethiopia
7
Germany
7
Kenya
7
Zambia
6
Eastern Europe
6
Ghana
5
Uganda
5
Nepal
5
Tanzania
5
Botswana
5
Sierra Leone
4
Philippines
4
Nigeria
3
Brazil
3
Ukraine
3
Madagascar
3
Africa
3
Senegal
2
Zimbabwe
2
Rwanda
2
Eswatini/ Swaziland
2
Lesotho
2
Sri Lanka
2
Asia
2
Russia
2
Burkina Faso
1
Liberia
1
Congo, Democratic Republic of
1
USA
1
Cameroon
1
Cambodia
1
Bangladesh
1
Argentina
1
North Macedonia
1
Angola
1
Latin America and the Carribbean
1
Albania
1
France
1
Oman
1
Authors & Publishers
Publication Years
Category
Countries
115
Clinical Guidelines
42
Public Health
18
Capacity Building
14
Women & Child Health
9
Key Resources
7
Pharmacy & Technologies
2
Toolboxes
HIV
42
TB
37
Malaria
37
NTDs
14
Rapid Response
10
Cholera
9
Ebola & Marburg
5
Refugee
5
Mental Health
5
COVID-19
5
Polio
4
AMR
4
2.0 Rapid Response
4
Conflict
3
Pharmacy
3
Zika
2
Planetary Health
1
NCDs
1
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Revised National Tuberculosis Control Programme
The purpose of this document is to guide clinicians in the care of patients with or at risk of severe illness from influenza virus infection, including those caused by seasonal influenza viruses, pandemic influenza viruses and zoonotic (novel influenza A) viruses.
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde
...
There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change.
...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp
...
Joining efforts to control two trelated global epidemics.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd
...
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
